GD

Goodrx Holdings IncNASDAQ GDRX Stock Report

Last reporting period 30 Sep, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

2.565

Small

Exchange

XNAS - Nasdaq

GDRX Stock Analysis

GD

Uncovered

Goodrx Holdings Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

25/100

Low score

Market cap $B

2.565

Dividend yield

Shares outstanding

396.19 B

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 952 full-time employees. The company went IPO on 2020-09-23. The firm provides GoodRx platform, which aggregates and analyzes pricing data from a range of different sources. The platform provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharma manufacturers provide affordability solutions such as co-pay cards, patient assistance programs, care portals and other savings options. Its prescription transactions offering provides curated, geographically relevant price comparisons and negotiated prices on prescriptions

View Section: Eyestock Rating